Article

July 11, 2012

Introduction and Overview of Results from CLEOPATRA Trial

AJMC's Co-Editor-in-Chief, Michael E. Chernew, PhD, Lee N. Newcomer, MD, MHA, UnitedHealthcare, and Sandra M. Swain, MD, Washington Cancer Institute, Medstar Washington Hospital Center.

Related Content

Affordable Care Act | Image credit: Vitalii Vodolazskyi - stock.adobe.com

April 25th 2025

5 Challenges the Affordable Care Act Overcame in the Last 15 Years

Giuliana Grossi

As the Affordable Care Act passed its 15th anniversary this year, Supreme Court Justices continue to deliberate the fate of its preventive services mandate in Kennedy v Braidwood.

February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

Pharmaceuticals | Image credit: psphotography - stock.adobe.com

April 24th 2025

Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas

Pearl Steinzor

Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las Vegas, Nevada.

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

Breast Cancer research | Image Credit: vectorfusionart - stock.adobe.com .jpeg

April 23rd 2025

HHS Cuts Funding for NIH-Based Women's Health Initiative Threatening Decades-Long Study

Giuliana Grossi

Following the Trump Administration’s mandate to cut $2.6 billion in NIH contracts, the Women’s Health Initiative shares HHS will close its regional centers in September.

Diabetes monitoring | Image credit: abidika - stock.adobe.com

April 23rd 2025

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

Pearl Steinzor

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

Related Content

Panel Discussion Oncology Policy

Panel Discussion

Oncology

Policy

April 25th 2025

5 Challenges the Affordable Care Act Overcame in the Last 15 Years

Giuliana Grossi

As the Affordable Care Act passed its 15th anniversary this year, Supreme Court Justices continue to deliberate the fate of its preventive services mandate in Kennedy v Braidwood.

February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD

April 24th 2025

Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas

Pearl Steinzor

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

April 23rd 2025

HHS Cuts Funding for NIH-Based Women's Health Initiative Threatening Decades-Long Study

Giuliana Grossi

Following the Trump Administration’s mandate to cut $2.6 billion in NIH contracts, the Women’s Health Initiative shares HHS will close its regional centers in September.

April 23rd 2025

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

Pearl Steinzor

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.